Pocket Hematoma: A Call for Definition

Francesco DE Sensi1, Gennaro Miracapillo1, Alberto Cresti1

  • 1Cardiology Unit, Misericordia Hospital, Grosseto, Italy.

Insights

Pocket hematoma, a complication of cardiac implantable electronic devices, lacks a standard definition, hindering research. This study proposes a uniform definition and grading system for pocket hematoma to improve consistency in clinical practice and research.

Area of Science:

  • Cardiology
  • Medical Devices
  • Clinical Research

Background:

  • Pocket hematoma is a frequent complication following cardiac implantable electronic device (CIED) procedures.
  • It poses a risk for device infections, particularly in patients using anticoagulants or antiplatelet therapies.
  • Current literature shows significant variability in reported incidence rates due to inconsistent definitions of hematoma.

Purpose of the Study:

  • To address the lack of a standardized definition for pocket hematoma.
  • To propose a uniform definition and severity grading criteria for pocket hematoma.
  • To facilitate consistent comparisons and improve research in CIED procedures.

Main Methods:

  • Review of current literature on pocket hematoma and bleeding complications associated with CIED procedures.
  • Analysis of existing definitions and their impact on reported incidence rates.
  • Development of a proposed uniform definition and grading scale for pocket hematoma.

Main Results:

  • The incidence of pocket hematoma and related bleeding complications varies widely in existing studies.
  • This variability is primarily attributed to the lack of a universally accepted definition for pocket hematoma.
  • A proposed uniform definition and grading system are presented to standardize reporting.

Conclusions:

  • A standardized definition and grading system for pocket hematoma are crucial for accurate research and clinical practice.
  • Implementing a uniform definition will enable reliable comparisons across studies.
  • This will ultimately improve the understanding and management of pocket hematoma in CIED patients.

Related Concept Videos

Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
17.9K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
10.1K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
12.2K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.7K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
2.1K